Here you'll find the latest press releases on VIB research and other important news.
DNA sequencing provides insight into the blueprint of living cells and individuals and is now used in many aspects of biological sciences, medicine, biotechnology and forensic sciences. An ultrafast way to sequence DNA is to read the nucleotide letters of single DNA strands as they pass through a protein nanopore. A new study by the team of Prof. Han Remaut (VIB-VUB) in collaboration with Oxford Nanopore Technologies presents a nanopore that is engineered to hold two constrictions.
With the advent of super-resolution microscopy, scientists can study close protein associations better than ever before. In the latest edition of eLife, the team of Wim Annaert (VIB-KU Leuven) combines state-of-the-art imaging techniques to investigate the distribution of γ-secretase, a protein complex associated with both Alzheimer’s disease and cancer.
EMBO is an organization that unites leading researchers in the life sciences to promotes scientific excellence. Every year, new members are selected from among Europe’s top-scientists. This year, Jean-Christophe Marine (VIB-KU Leuven), Jan Steyaert (VIB-VUB), and Alain Goossens (VIB-UGent) join the other VIB EMBO members.
Every five years, the Research Foundation Flanders (FWO) awards the prestigious Excellence Prizes to eminent Flemish researchers with a distinguished career in science. In 2020, two VIB researchers working at Ghent University have received this important recognition for their outstanding scientific career and dedication to research: Prof. Bart Lambrecht (VIB-UGent Center for Inflammation Research) and prof. Wout Boerjan (VIB-UGent Center for Plant Systems Biology).
In recognition of his outstanding work in rheumatology, Prof. Dirk Elewaut (VIB-UGent Center for Inflammation Research and Ghent University Hospital) is the first Belgian scientist to receive the Carol Nachman prize. This award is considered as the world’s highest honor awarded to a rheumatologist.
Two mutations identified in individuals with developmental and epileptic brain disease can be traced back to the same ion channel. Researchers have now elucidated how both independent mutations affect the channel’s function: by making it overly active and highly sensitive to stimulation. The findings are an important step towards unraveling what causes the patients’ symptoms.
A collaborative study by research groups from the VIB-UGent Center for Inflammation Research and Ghent University uncovered a new mechanism causing colorectal cancer. The researchers found that abnormal expression of the protein Zeb2 affects the integrity of the intestinal wall or ‘epithelium’.
Leuven researchers have deployed synthetic amyloids to trigger protein misfolding as a strategy to combat the influenza A and Zika virus.
In a recent study in JAMA Neurology, a Leuven research team led by Prof. Philip Van Damme, reveals that FDG-PET imaging is an early and sensitive biomarker to detect cerebral metabolic changes in presymptomatic carriers of a C9orf72 mutation. Their findings suggest that FDG-PET captures early cerebral changes years before disease onset.
The Chan Zuckerberg Initiative announced $3.8 million in funding for 23 grants to support open-source software projects essential to biomedical research. Software by the lab of Yvan Saeys (VIB-UGent) for the analysis and visualization of single-cell data is one of the projects that will receive funding as part of CZI’s Essential Open Source Software for Science (EOSS) program.
Single cell technologies provide unprecedented insights into the dynamics of gene regulation of individual cells, but resolving spatiotemporal regulation networks has remained an experimental and computational challenge. A team of scientists lead by Stein Aerts (VIB-KU Leuven) came up with a new approach to map gene regulation in 2D tissues.
Ghent, May 14, 2020. A team of VIB researchers led by Dr Hilde Nelissen and Prof Dirk Inzé are starting a field trial today with a maize variety that is better adapted to drought.
With a discovery that could rewrite the immunology textbooks, an international group of scientists, including the teams of Bart Lambrecht, Martin Guilliams, Hamida Hammad, and Charlotte Scott (all from the VIB-UGent Center for Inflammation Research) identified a new type of antigen-presenting immune cell.
In 2012, the European Union MetaCardis consortium, comprising 14 research groups from six European countries with multidisciplinary expertise set out to investigate a potential role of the gut microbiota in the development of cardio-metabolic diseases.
The lab of Xavier Saelens (VIB-UGent Center for Medical Biotechnology) announces the isolation and characterization of a unique antibody that can bind to the virus that causes COVID-19 (SARS-CoV-2). The antibody was described in collaboration with research groups in the US.